Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
about
Cabozantinib in the treatment of hepatocellular carcinoma.Cabozantinib for the treatment of kidney cancer.Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.A network meta-analysis of short-term efficacy of different single-drug targeted therapies in the treatment of renal cell carcinoma.An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma.Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma.Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospects.The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells.Systemic treatment for hepatocellular carcinomaSystemic treatments for hepatocellular carcinoma: challenges and future perspectivesUpdate on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)The Expanding Role of Systemic Therapy in the Management of Hepatocellular CarcinomaPotential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
P2860
Q38658285-EBF31EDB-E8DD-40D7-968A-25410F4AB515Q38668871-219635E6-8A87-4B52-A70E-E17191F5954EQ41547474-887CFAF2-57FA-434C-8BEA-7F81F813CBE2Q47143379-2EDF4BC1-F806-4569-A8D1-6816E33C1691Q47954829-B19EA220-F9D8-41DF-A104-42EEB0B9EC6CQ49953442-1C14A00B-2966-4FCC-BE53-A6C283F0F05EQ55223567-223CAAB4-DD4E-44C9-A6E0-C1F0A946BF19Q55437410-010C3D68-1C4B-4707-A2D2-4D3314806533Q57074295-4A2D435D-7A0E-4E3B-AD68-B4E529536543Q57301434-EC144643-DE34-46C9-BA54-07D375C93C05Q57484611-98E03783-18CC-451D-8B7A-925BC3A58E1AQ58797003-F6037642-D5A8-4CB6-B9F2-6F631D2E89F6Q59125907-085A3FE2-6B04-4913-A98C-7FDE86508F5C
P2860
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@ast
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@en
type
label
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@ast
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@en
prefLabel
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@ast
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@en
P2093
P2860
P356
P1433
P1476
Cabozantinib in hepatocellular ...... ndomized discontinuation study
@en
P2093
C Verslype
E Van Cutsem
N Vogelzang
R K Kelley
P2860
P304
P356
10.1093/ANNONC/MDW651
P50
P577
2017-03-01T00:00:00Z